These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
5. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression. López-Peláez M; Soria-Castro I; Boscá L; Fernández M; Alemany S Eur J Immunol; 2011 Jun; 41(6):1733-41. PubMed ID: 21469113 [TBL] [Abstract][Full Text] [Related]
6. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Zachary I; Gliki G Cardiovasc Res; 2001 Feb; 49(3):568-81. PubMed ID: 11166270 [TBL] [Abstract][Full Text] [Related]
7. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A. Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Loniewski KJ; Patial S; Parameswaran N Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
11. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy. Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746 [TBL] [Abstract][Full Text] [Related]
12. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Kroll J; Waltenberger J Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function. Smith GA; Fearnley GW; Abdul-Zani I; Wheatcroft SB; Tomlinson DC; Harrison MA; Ponnambalam S Biol Open; 2017 Oct; 6(10):1404-1415. PubMed ID: 28798148 [TBL] [Abstract][Full Text] [Related]
14. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Landgren E; Schiller P; Cao Y; Claesson-Welsh L Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961 [TBL] [Abstract][Full Text] [Related]
15. [Activation of signal transducers and activators of transcription induced by vascular endothelial growth factor in CD34+ hematopoietic progenitor cells in vitro]. Ye F; Ye DF; Xie X; Chen HZ; Lü WG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):12-7. PubMed ID: 15052767 [TBL] [Abstract][Full Text] [Related]
16. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193 [TBL] [Abstract][Full Text] [Related]